Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on mental health, vaccination, telehealth, and racial inequities in healthcare.
Noguchi started her career as a reporter, then an editor, for The Washington Post, primarily covering business and technology. Noguchi joined NPR as a business correspondent in 2008, just before the financial crisis and Great Recession. She has covered a wide range of issues, from the workplace to the earthquake and tsunami in her parents' native Japan in 2011. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award as well as First Place and Best In Show in the radio category from the National Headliner Awards. Her work on medical debt, in partnership with Kaiser Health News, won a 2023 Gerald Loeb award and an award from the National Institutes of Health Care Management.
Noguchi grew up in St. Louis, likes to cook, has a degree in history from Yale and is raising two boys and two rescue dogs outside Washington DC.
-
Lung cancer is still the top cancer killer. But new developments are shifting what the future might hold for patients, as one man's cancer journey shows.
-
The FDA just approved a breakthrough drug for metastatic pancreatic cancer, which is notoriously hard to treat. In clinical trials, the new pill roughly doubled how long patients survived.
-
Amid a record-setting outbreak of the diarrhea-causing parasite, food safety advocates say risks to food production are increasing.
-
Recalls of lettuce, jalapeno peppers and eggs because of foodborne illness outbreaks have put a spotlight on the safety of the U.S. food supply. How much do the recalls tell us?